Home›Trandolapril Tablets›Trandolapril Tablets + Trandolapril

Does Trandolapril Tablets Interact with Trandolapril?

CDI records a major classification for Trandolapril Tablets and Trandolapril. The stored summary is: Closely monitor blood pressure, renal function and electrolytes in patients on trandolapril and other agents that affect the RAS. Avoid use of aliskiren with trandolapril in patients with renal impairment (GFR <60 ml/min). Concomitant Diuretic Therapy As with other ACE inhibitors, patients on diuretics, especially those on recently instituted diuretic therapy, may experience an excessive reduction of blood pressure after initiation of therapy with trandolapril. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Trandolapril Tablets Class
Angiotensin Converting Enzyme Inhibitor
Trandolapril Class
Angiotensin Converting Enzyme Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Trandolapril Tablets and your doctor is considering prescribing Trandolapril (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Trandolapril Tablets(Trandolapril)+💊 Trandolapril

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin Converting Enzyme Inhibitor
Drug B class
Angiotensin Converting Enzyme Inhibitor
Source
FDA drug label - trandolapril tablets

What this means in plain English

Closely monitor blood pressure, renal function and electrolytes in patients on trandolapril and other agents that affect the RAS. Avoid use of aliskiren with trandolapril in patients with renal impairment (GFR <60 ml/min). Concomitant Diuretic Therapy As with other ACE inhibitors, patients on diuretics, especially those on recently instituted diuretic therapy, may experience an excessive reduction of blood pressure after initiation of therapy with trandolapril.

About Trandolapril Tablets and Trandolapril

Trandolapril Tablets and Trandolapril both belong to the Angiotensin Converting Enzyme Inhibitor class. Both Trandolapril Tablets and Trandolapril carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: FDA drug label - trandolapril tablets

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Trandolapril Tablets and Trandolapril against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations